Full-Time

Governance and Controls lead

Updated on 9/3/2026

Inizio

Inizio

5,001-10,000 employees

Guides clinical development and commercialization

No salary listed

Manchester, UK

Hybrid

Hybrid role in Manchester with on-site days; some activities may be conducted remotely.

Bachelor's

Category
Accounting (1)
Required Skills
Risk Management

Get referred to Inizio

See people who can refer or advise you

Requirements
  • Bachelor's degree or equivalent professional qualification in Finance, Accounting, Business Administration or a related discipline
  • Professional accountancy qualification (ACA, ACCA, CIMA or equivalent) required
  • Significant experience in SOX compliance, internal controls and audit management within a global Shared Services Centre (SSC) or Global Business Services (GBS) environment, with significant Record To Report (RTR) process exposure - essential
  • Experience leading control frameworks, designing and operating CSA programmes and coordinating internal and external audit activity across a multi-process shared services environment required
  • Strong knowledge of SOX, internal controls and GFS process environments (RTR, PTP, OTC and Payroll)
  • Master data governance, KPI reporting and performance management expertise
  • Strong stakeholder management and ability to influence senior leaders
  • Independent judgement and strong governance mindset
  • Collaborative leader focused on quality, compliance and continuous improvement
Responsibilities
  • Maintain and evolve the GFS SOX control framework across all process towers
  • Set standards for control documentation, evidence quality and cross-process consistency
  • Lead the CSA programme within RTR and coordinate CSA activity across GFS in partnership with the Governance and Compliance Lead, OTC and the PTP Process Excellence Lead, ensuring consistent methodology, evidence standards and follow-through on findings
  • Act as the primary liaison for internal and external audit within RTR, coordinating management testing, reviewing outcomes and driving remediation
  • Coordinate audit activity at a GFS level, consolidating outcomes and reporting across towers in partnership with the Governance and Compliance Lead, OTC and the PTP Process Excellence Lead
  • Own quality standards across GFS through KPI, SLA and error trend monitoring
  • Lead master data governance and data quality standards for vendors and customers
  • Identify and escalate operational, financial and compliance risks across GFS, working with Heads of Function and tower governance leads to ensure risks are addressed and lessons learned are embedded into process design
  • Act as the governance gate for new processes, system implementations and scope migrations into GFS, ensuring control readiness is demonstrated before go-live within RTR and that GFS-wide standards are applied consistently across towers
  • Provide governance reporting and insight to GFS and Finance leadership
  • Report on service quality performance across GFS process towers, including KPI, SLA and error trend analysis, providing GFS and Finance leadership with clear and timely insight on process health and emerging risks
  • Lead and develop the master data and performance insight team
  • Manage the GFS intern programme in partnership with a local university
  • Use CSA results, audit outcomes and service quality data to identify emerging risks and improvement opportunities, escalating findings to the relevant Head of Function or tower governance lead and tracking remediation to closure
Desired Qualifications
  • Experience owning or governing finance master data, including vendor and customer master data, within a controlled shared services environment is advantageous

Inizio helps health and life sciences companies develop and commercialize products to maximize patient access. It uses a connected suite of capabilities and expert guidance to navigate assets through their entire lifecycle with tailored strategies. Unlike firms that offer single services, Inizio combines multiple capabilities in an end-to-end approach focused on reducing complexity and ensuring lifecycle support. Its goal is to bring therapies to patients faster and more effectively by coordinating development, regulatory, market access, and commercialization activities to maximize value and treatment outcomes.

Company Size

5,001-10,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

N/A

Get referred to Inizio

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Inizio launched Connected Insights on July 28, 2026, expanding APAC medical-information services.
  • On May 12, 2026, Intelligent Congress added measurable analytics to a high-spend commercial offering.
  • Hub Services launched April 23, 2026, strengthening patient access, reimbursement, and adherence programs.

What critics are saying

  • The 2025 annual report showed a $16.7 million restructuring charge and workforce streamlining.
  • Headcount fell from 10,872 in 2023 to 10,004 by March 2026.
  • Big pharma clients can consolidate vendors or insource services, crushing Inizio's outsourced margin base.

What makes Inizio unique

  • Inizio serves 100% of top 20 pharma across 50 countries and 175 congresses yearly.
  • Its integrated model spans medical affairs, congresses, patient access, and commercialization execution.
  • Inizio embeds AI across workflows, from voice analytics to virtual agents and training personas.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Performance Bonus

Professional Development Budget

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

7%
PR Newswire
Jul 28th, 2026
Inizio launches AI-enabled Connected Insights to transform medical information into strategic intelligence

Inizio has expanded its Global Medical Information capabilities through Inizio Engage, launching Connected Insights to help pharmaceutical and biotechnology companies transform medical information into strategic intelligence. The service combines expanded Asia-Pacific expertise, enhanced global infrastructure, and AI-enabled innovation. The company supports more than one million medical information interactions annually across 500+ products in 55+ global programmes, delivering services in over 20 languages. AI-powered features have increased training simulations tenfold and improved training success by 50%. The expansion includes continued growth across the APAC region, expanded global infrastructure, and AI-enabled innovations throughout the medical information workflow, including AI-powered training personas, speech analytics, and virtual agents. The investment reinforces Inizio's commitment to connecting scientific expertise with technology and data-driven insight across the product lifecycle.

PR Newswire
May 12th, 2026
Inizio launches Intelligent Congress solution to measure medical event impact

Inizio, a global commercialisation partner to health and life sciences companies, has launched Intelligent Congress, an end-to-end solution designed to maximise the value of medical congress investments and deliver measurable business impact. The platform addresses fragmented planning and unclear objectives that often dilute congress opportunities. It integrates strategy, experience design, delivery and measurement across the full congress lifecycle, enabling clients to focus on meaningful shifts in healthcare professional engagement and behaviour rather than isolated metrics. Intelligent Congress uses a four-step framework spanning the entire congress calendar, capturing real-time insights and evaluating impact against key datasets. Inizio has supported over 80 clients across 27 countries, facilitating more than 1,000 healthcare professional engagements and managing over 25,500 attendees.

PR Newswire
Apr 23rd, 2026
Inizio launches integrated hub services combining analytics, pharmacy and specialist support to improve patient access

Inizio has launched its fully integrated Hub Services through its Inizio Engage business unit, targeting improved patient access, reimbursement and adherence for life sciences companies. The solution combines advanced analytics, pharmacy capabilities and specialised expertise to streamline the patient journey. The offering includes non-dispensing pharmacy services for benefit verification and fulfilment coordination, comprehensive access and reimbursement support, field reimbursement services and non-commercial dispensing pharmacy. Advanced analytics predict potential delays before they occur. Inizio Engage, which employs over 6,000 experts across 20 countries and delivers over 5 million engagements annually, will showcase the service at the Asembia Summit in Las Vegas from 27–30 April 2026. The company has made significant investments in leadership across patient access, pharmacy, reimbursement and analytics to support the service.

PR Newswire
Feb 6th, 2025
Inizio Accelerates Growth With A Trio Of Strategic Leadership Appointments

LONDON, Feb. 6, 2025 /PRNewswire/ -- Inizio, a commercialization partner for health and life science companies, has today announced the appointment of Colin Stanley as Chief Commercial Officer (CCO), Remco op den Kelder as President of Inizio Advisory and Jim Sage as President of Inizio Engage.Stepping into the CCO role, Colin brings over 25 years of sector experience and a proven track record in business growth in the industry, from CRO and commercialization

Bio-IT World
Oct 20th, 2024
Inizio Medical Appoints Patrick Giordani as SVP, AI Solutions Architect, Underpinning Commitment to Expanding AI Capabilities and Accelerating Innovation

Inizio Medical, the leading provider of Medical Affairs and communications solutions, today announced the appointment of Patrick Giordani as Senior Vice President, AI Solutions Architect.